Skip to main content
CHC logo

CHC — Investor Relations & Filings

Ticker · 4164 ISIN · TW0004164009 TW Wholesale and retail trade
Open in API
Filings indexed 2,275 across all filing types
Latest filing 2016-04-07 Director's Dealing
Country TW Taiwan
Listing TW 4164

About CHC

www.chcg.com

CHC Healthcare Group is a provider of comprehensive medical equipment, technology, and management services. The company offers one-stop solutions ranging from equipment distribution and leasing to operational consulting and hospital management. Its extensive portfolio covers specialized fields such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, dentistry, and rehabilitation. Representing over 30 international brands, the group is a major distributor of high-end medical devices and a leader in oncology equipment. Beyond equipment sales and maintenance, the company has expanded into long-term care, radiation sterilization services, and chain pharmacy channels. With a focus on smart healthcare and advanced medical technologies, the group supports healthcare providers through technical maintenance, personnel training, and integrated department construction across the Asia-Pacific region.

Recent filings

Filing Released Lang Actions
105年03月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings and changes in share ownership by insiders such as directors, supervisors, general manager, deputy general managers, and major shareholders. It includes specific data on stock types, quantities held at different times, increases and decreases in holdings, and notes on identities. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate filings. There is no indication of a report publication, earnings release, or regulatory certification. The document is a detailed insider shareholding disclosure, which corresponds to the category of Director's Dealing (DIRS).
2016-04-07 Chinese
105年03月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, supervisors, and senior management. It focuses on the personal shareholdings and pledges of insiders rather than financial results, management changes, or other corporate events. This matches the definition of a Director's Dealing report, which reports personal share transactions or holdings by company directors and executives. The document is about insider shareholdings and pledges, not about changes in management or board composition, nor is it a general regulatory filing or announcement. Therefore, the appropriate classification is Director's Dealing (DIRS). The document length is 3017 characters, which is sufficient for a detailed insider shareholding report, not a brief announcement.
2016-04-07 Chinese
104年第4季海外子公司投資
Regulatory Filings Classification · 95% confidence The document is a short disclosure from a public information observation station regarding investment in overseas subsidiaries, showing investment amounts, shareholding percentages, and recognized investment gains or losses for a specific quarter (104th year, 4th quarter). It contains tabular financial data but is very brief (720 characters) and does not constitute a full financial report such as an Annual Report (10-K) or Interim Report (IR). It appears to be a regulatory disclosure or filing related to investment holdings rather than a full report or announcement of a meeting or vote. Given the brevity and nature, it fits best under Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory disclosures that do not fit other categories.
2016-03-29 Chinese
104年第4季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes specific financial figures, investment methods, and regulatory limits as per the Ministry of Economic Affairs Investment Commission. The document length is 1403 characters, which is relatively short and the content is focused on investment details rather than a full financial report. There is no indication that this is an announcement of a report publication or a certification. The content aligns with a regulatory disclosure related to investment activities and compliance with investment limits, which typically falls under general regulatory filings. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2016-03-29 Chinese
104年度財務比率
Fund Information / Factsheet Classification · 90% confidence The document contains a financial data analysis summary for the company 承業醫 over three fiscal years (102, 103, 104年度). It includes various financial ratios and performance metrics such as debt ratio, liquidity ratios, turnover rates, profitability ratios, and cash flow ratios. The document is relatively short (1010 characters) and presents summarized financial data without detailed financial statements or comprehensive analysis. It does not appear to be a full annual or interim report, nor does it contain management discussion or regulatory certifications. The content resembles a brief financial factsheet or summary of key financial metrics over multiple years, which aligns with the definition of Fund Information / Factsheet (FS).
2016-03-29 Chinese
104年第4季資產負債表
Annual Report Classification · 85% confidence The document contains a consolidated balance sheet with detailed financial data for two fiscal years ending December 31, 2015 and 2014 (民國104年 and 103年). It includes comprehensive financial statement line items such as current assets, non-current assets, liabilities, and equity. The presence of actual financial figures and the nature of the content indicate this is a financial report rather than an announcement or summary. The document length is 3672 characters, which is relatively short but contains substantive financial data. Given the detailed financial statements for a full fiscal year, this fits the definition of an Annual Report (10-K) or a similar comprehensive yearly financial report. However, since the document is specifically a consolidated balance sheet for the year-end, and no other context is given, it is most consistent with an Interim / Quarterly Report (IR) if it is a quarterly or interim period, or Annual Report (10-K) if it is a full year. The dates correspond to year-end, so it is likely an Annual Report. However, the document is only a balance sheet, not a full annual report with management discussion and notes. Given the document length and content, it is more consistent with an Interim / Quarterly Report (IR) which contains actual financial statements for a period shorter than a full fiscal year or a quarterly report. But since the dates are year-end, it is more likely an Annual Report (10-K). The document is in Chinese and from a Taiwanese company, but the classification system is based on US SEC forms. The best fit is Annual Report (10-K) due to the year-end consolidated financial statements provided. Q4 2015
2016-03-29 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.